TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 69 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is 2.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $376,270 | -70.9% | 9,978 | -70.7% | 0.00% | -100.0% |
| Q2 2023 | $1,292,124 | -1.1% | 34,066 | -36.6% | 0.00% | 0.0% |
| Q1 2023 | $1,305,838 | -19.2% | 53,694 | -3.5% | 0.00% | -50.0% |
| Q4 2022 | $1,616,134 | -2.4% | 55,652 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $1,656,000 | -20.8% | 55,249 | -4.5% | 0.00% | 0.0% |
| Q2 2022 | $2,091,000 | -18.3% | 57,832 | -2.2% | 0.00% | 0.0% |
| Q1 2022 | $2,559,000 | -8.8% | 59,145 | +5.6% | 0.00% | 0.0% |
| Q4 2021 | $2,806,000 | -25.5% | 56,001 | -5.4% | 0.00% | -33.3% |
| Q3 2021 | $3,767,000 | -16.0% | 59,196 | -5.0% | 0.00% | -25.0% |
| Q2 2021 | $4,486,000 | -9.0% | 62,344 | -6.7% | 0.00% | -20.0% |
| Q1 2021 | $4,928,000 | -13.5% | 66,815 | -13.9% | 0.01% | 0.0% |
| Q4 2020 | $5,699,000 | +26.7% | 77,624 | -5.3% | 0.01% | 0.0% |
| Q3 2020 | $4,498,000 | -20.9% | 82,010 | -4.2% | 0.01% | -28.6% |
| Q2 2020 | $5,690,000 | +7.4% | 85,576 | -1.1% | 0.01% | -12.5% |
| Q1 2020 | $5,298,000 | -34.6% | 86,560 | -6.1% | 0.01% | -11.1% |
| Q4 2019 | $8,106,000 | +60.2% | 92,196 | +37.4% | 0.01% | +50.0% |
| Q3 2019 | $5,061,000 | +60.4% | 67,078 | +81.6% | 0.01% | +50.0% |
| Q2 2019 | $3,156,000 | +6.9% | 36,946 | +35.2% | 0.00% | 0.0% |
| Q1 2019 | $2,953,000 | -16.6% | 27,322 | -34.7% | 0.00% | -20.0% |
| Q4 2018 | $3,542,000 | -40.3% | 41,845 | -30.7% | 0.01% | -28.6% |
| Q3 2018 | $5,933,000 | +24.7% | 60,351 | +46.7% | 0.01% | +16.7% |
| Q2 2018 | $4,759,000 | +35.4% | 41,135 | +15.6% | 0.01% | +20.0% |
| Q1 2018 | $3,515,000 | +33.8% | 35,592 | +41.8% | 0.01% | +25.0% |
| Q4 2017 | $2,628,000 | +1083.8% | 25,098 | +1218.2% | 0.00% | – |
| Q1 2017 | $222,000 | -80.7% | 1,904 | -75.9% | 0.00% | -100.0% |
| Q2 2016 | $1,150,000 | -13.3% | 7,900 | -14.7% | 0.00% | 0.0% |
| Q1 2016 | $1,326,000 | +48.8% | 9,259 | +60.6% | 0.00% | +100.0% |
| Q4 2015 | $891,000 | +216.0% | 5,767 | +188.4% | 0.00% | – |
| Q1 2015 | $282,000 | -4.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2014 | $296,000 | -59.7% | 2,000 | -58.1% | 0.00% | -100.0% |
| Q3 2014 | $735,000 | -35.6% | 4,774 | -41.3% | 0.00% | -50.0% |
| Q2 2014 | $1,141,000 | -53.6% | 8,138 | -67.3% | 0.00% | -33.3% |
| Q4 2013 | $2,458,000 | -23.3% | 24,852 | -41.0% | 0.00% | -40.0% |
| Q3 2013 | $3,203,000 | +26.9% | 42,140 | -6.7% | 0.01% | 0.0% |
| Q2 2013 | $2,524,000 | – | 45,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |